Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Thursz

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
QJM : Monthly Journal of the Association of Physicians|March 31, 1998
Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in AfricansR Bellamy, C Ruwende, K P McAdam, et al.
Alimentary Pharmacology & Therapeutics|December 7, 2013
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The GambiaM Lemoine, Y Shimakawa, R Njie, et al.
Journal of Viral Hepatitis|January 19, 2005
Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trialM Wright, D Forton, J Main, et al.
East African Medical Journal|November 1, 1995
Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver diseaseO S Ojo, M Thursz, H C Thomas, et al.
Gut Microbes|January 18, 2024
Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitusR Forlano, L Martinez-Gili, P Takis, et al.
The Journal of Infectious Diseases|April 1, 1994
Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.
Nature Communications|February 16, 2018
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infectionA M Ortega-Prieto, J K Skelton, S N Wai, et al.
Journal of Medical Genetics|March 1, 2006
Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infectionR Dawes, B Hennig, W Irving, et al.
Journal of Viral Hepatitis|June 30, 2016
Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countriesS Ghosh, A Sow, C Guillot, et al.
Health Technology Assessment (Winchester, England)|September 18, 2008
The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trialA Grant, S Wileman, C Ramsay, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
QJM : Monthly Journal of the Association of Physicians|March 31, 1998
Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in AfricansR Bellamy, C Ruwende, K P McAdam, et al.
Alimentary Pharmacology & Therapeutics|December 7, 2013
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The GambiaM Lemoine, Y Shimakawa, R Njie, et al.
Journal of Viral Hepatitis|January 19, 2005
Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trialM Wright, D Forton, J Main, et al.
East African Medical Journal|November 1, 1995
Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver diseaseO S Ojo, M Thursz, H C Thomas, et al.
Gut Microbes|January 18, 2024
Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitusR Forlano, L Martinez-Gili, P Takis, et al.
The Journal of Infectious Diseases|April 1, 1994
Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.
Nature Communications|February 16, 2018
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infectionA M Ortega-Prieto, J K Skelton, S N Wai, et al.
Journal of Medical Genetics|March 1, 2006
Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infectionR Dawes, B Hennig, W Irving, et al.
Journal of Viral Hepatitis|June 30, 2016
Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countriesS Ghosh, A Sow, C Guillot, et al.
Health Technology Assessment (Winchester, England)|September 18, 2008
The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trialA Grant, S Wileman, C Ramsay, et al.
Pageof 5